Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  TAN LIP BU
2. Date of Event Requiring Statement (Month/Day/Year)
11/10/2010
3. Issuer Name and Ticker or Trading Symbol
INPHI Corp [IPHI]
(Last)
(First)
(Middle)
ONE CALIFORNIA ST., SUITE 2800
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN FRANCISCO, CA 94111
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Preferred Stock   (1)   (1) Common Stock 23,260 $ (1) I By Asian Venture Capital Investment Corporation (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 23,260 $ (1) I By International Venture Capital Investment Corporation (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 23,260 $ (1) I By International Venture Capital Investment III Corp. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 18,425 $ (1) I By Pacven Walden Ventures Parallel V-A C.V. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 18,425 $ (1) I By Pacven Walden Ventures Parallel V-B. C.V. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 1,960 $ (1) I By Pacven Walden Ventures V Associates Fund, L.P. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 799,549 $ (1) I By Pacven Walden Ventures V, L.P. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 12,889 $ (1) I By Pacven Walden Ventures V-QP Associates Fund, L.P. (2) (3)
Series B Preferred Stock   (1)   (1) Common Stock 40,705 $ (1) I By Seed Ventures III Ptd Ltd. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 28,094 $ (1) I By Asian Venture Capital Investment Corporation (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 28,094 $ (1) I By International Venture Capital Investment Corporation (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 28,094 $ (1) I By International Venture Capital Investment III Corp. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 22,195 $ (1) I By Pacven Walden Ventures Parallel V-A C.V. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 22,195 $ (1) I By Pacven Walden Ventures Parallel V-B. C.V. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 54,466 $ (1) I By Pacven Walden Ventures Parallel VI, L.P. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 2,361 $ (1) I By Pacven Walden Ventures V Associates Fund, L.P. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 963,153 $ (1) I By Pacven Walden Ventures V, L.P. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 699,488 $ (1) I By Pacven Walden Ventures VI, L.P. (2) (3)
Series C Preferred Stock   (1)   (1) Common Stock 15,527 $ (1) I By Pacven Walden Ventures V-QP Associates Fund, L.P. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 7,856 $ (1) I By Asian Venture Capital Investment Corporation (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 7,856 $ (1) I By International Venture Capital Investment Corporation (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 7,856 $ (1) I By International Venture Capital Investment III Corp. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 6,214 $ (1) I By Pacven Walden Ventures Parallel V-A C.V. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 6,214 $ (1) I By Pacven Walden Ventures Parallel V-B. C.V. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 8,176 $ (1) I By Pacven Walden Ventures Parallel VI, L.P. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 661 $ (1) I By Pacven Walden Ventures V Associates Fund, L.P. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 269,653 $ (1) I By Pacven Walden Ventures V, L.P. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 105,011 $ (1) I By Pacven Walden Ventures VI, L.P. (2) (3)
Series D Preferred Stock   (1)   (1) Common Stock 4,347 $ (1) I By Pacven Walden Ventures V-QP Associates Fund, L.P. (2) (3)
Series E Preferred Stock   (1)   (1) Common Stock 5,589 $ (1) I By Pacven Walden Ventures Parallel V-A C.V. (2) (3)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
TAN LIP BU
ONE CALIFORNIA ST., SUITE 2800
SAN FRANCISCO, CA 94111
  X      

Signatures

/s/ Lip-Bu Tan 11/10/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The convertible preferred stock is convertible at anytime, at the holder's option, on a one-for-one basis and has no expiration date.
(2) The Reporting Person is the sole director of Pacven Walden Management V Co. Ltd,. which is the general partner of Pacven Walden Ventures V, L.P., Pacven Walden Ventures Parallel V-A C.V., Pacven Walden Ventures Parallel V-B C.V., Pacven Walden Ventures V Associates Fund, L.P. and Pacven Walden Ventures V-QP Associates Fund, L.P., or Pacven V and affiliated funds. He is also the sole director of Pacven Walden Management VI Co. Ltd., which is the general partner of Pacven Walden Ventures VI, L.P. and Pacven Walden Ventures Parallel VI, L.P., or Pacven VI and Parallel Funds. The Reporting Person is also the president of each of Asian Venture Capital Investment Corporation, International Venture Capital Investment Corporation and International Venture Capital Investment III Corp. (Continued in footnote 3)
(3) The Reporting Person may be deemed to have shared voting and dispositive power over the shares which are, or may be, deemed to be beneficially owned by Asian Venture Capital Investment Corporation, International Venture Capital Investment Corporation, International Venture Capital Investment III Corp., Pacven Walden Ventures Parallel V-A C.V., Pacven Walden Ventures Parallel V-B. C.V., Pacven Walden Ventures Parallel VI, L.P., Pacven Walden Ventures V Associates Fund, L.P., Pacven Walden Ventures V, L.P., Pacven Walden Ventures VI, L.P., Pacven Walden Ventures V-QP Associates Fund, L.P. or Seed Ventures III Ptd Ltd., but disclaims such beneficial ownership except to the extent of his or her pecuniary interest therein.
 
Remarks:
Form 1 of 2

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.